Phase II Safety and Efficacy Study of Crizotinib in East Asian Patients With ROS1 Positive, ALK Negative Advanced NSCLC

Department of Medical Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Chaoyang District

307 Hospital of PLA/Department of Lung Cancer, Fengtai District

Beijing Cancer Hospital, Department of Thoracic Oncology, Haidian District

The Military General Hospital of Beijing PLA / Medical Oncology Dept., Dongcheng District

Chinese PLA General Hospital, Haidian District

Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai

Shanghai Chest Hospital/Lung cancer clinical center, Shanghai

Zhongshan Hospital Fudan University / Respiratory Department, Xuhui District

Shanghai Pulmonary Hospital, Shanghai

The First Affiliated Hospital of Anhui Medical University, Department of Medical Oncology, Hefei

The affiliated hospital of medical college Qingdao University / Medical oncology department, Qingdao

Department of Thoracic Oncology, Tianjin Medical University Cancer Institute and Hospital, Hexi District

The First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou

Sir Run Run Shaw Hospital of College of Medicine of Zhejiang University, Center for Oncology, Hangzhou

Fujian Province Oncology Hospital, Fuzhou

Respiration department,the First Affiliated Hospital of Third Military Medical University, PLA, Shapingba District

Hunan Provincial Tumor Hospital/Division of Oncology, Changsha

SUN Yat-Sen University Cancer Center, Guangzhou

The First Affiliated Hospital of Guangzhou Medical College, Guangzhou

Oncology Department, West China Hospital of Sichuan University, Chengdu

Sichuan Province Cancer Hospital/Department of Pulmonary Tumor, Chengdu

Beijing Chest Hospital, Tongzhou District

Guangdong General Hospital, Guangzhou

Department of Oncology, Jilin Provincial Cancer Hospital, Changchun

Zhejiang Cancer Hospital, Hangzhou

Aichi Cancer Center Hospital, Aichi

National Cancer Center Hospital East, Chiba

NHO Shikoku Cancer Center, Ehime

NHO Kyushu Cancer Center, Fukuoka

Hyogo Cancer Center, Hyōgo

Tohoku University Hospital, Miyagi

Kinki University Hospital, Osaka

Osaka City General Hospital, Osaka

Cancer Institute Hospital of JFCR, Tokyo

National Cancer Center Hospital, Tokyo

Asan Medical Center, Seoul

Samsung Medical Center, Seoul

Seoul National University Hospital, Seoul

Yonsei University, Severance Hospital, Seoul

Taichung Veterans General Hospital, Taichung

National Cheng Kung University Hospital, Tainan City

National Taiwan University Hospital, Taipei

Taipei Veterans General Hospital, Taipei

Shizuoka Cancer Center, Sunto-gun